# Bioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention.

> PubMed lists PMID 28396341 in Cancer prevention research (Philadelphia, Pa.) as Clinical Trial, Journal Article, with publication-date metadata of 2017-04-10 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings.

- Evidence object: `story:pubmed-pmid-28396341-linaclotide:v1`
- Evidence domain: Literature metadata
- Date in source: 2025-01-03
- Source checked: 2026-07-30
- Published by PeptideScanner: 2026-08-13
- Story landing page: https://peptidescanner.com/stories/pubmed-pmid-28396341-linaclotide/
- JSON record: https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-28396341-linaclotide-v1.json
- Content SHA-256: `5deb397ed9a9a369ead090e30697e38ec7a5e87f4135f5fc07fb08c26ba70f90`

## Claims and source pins

### Headline

Bioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention. ([`pubmed-observation-pmid-28396341-2025-01-03-628404c7fcb9`](#source-pubmed-observation-pmid-28396341-2025-01-03-628404c7fcb9))

### Summary

PubMed lists PMID 28396341 in Cancer prevention research (Philadelphia, Pa.) as Clinical Trial, Journal Article, with publication-date metadata of 2017-04-10 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-28396341-2025-01-03-628404c7fcb9`](#source-pubmed-observation-pmid-28396341-2025-01-03-628404c7fcb9))

### Paragraph 1

PubMed lists PMID 28396341 in Cancer prevention research (Philadelphia, Pa.) as Clinical Trial, Journal Article, with publication-date metadata of 2017-04-10 (day precision). PeptideScanner associated the retained record with the identity slug linaclotide. These fields reproduce attributed bibliographic metadata and do not summarize or endorse the article's findings. ([`pubmed-observation-pmid-28396341-2025-01-03-628404c7fcb9`](#source-pubmed-observation-pmid-28396341-2025-01-03-628404c7fcb9))

### Paragraph 2

This page reproduces bounded bibliographic metadata attributed to PubMed. Its title and publication details are source metadata, not PeptideScanner's endorsement or an assertion of safety, efficacy, or scientific truth. ([`pubmed-observation-pmid-28396341-2025-01-03-628404c7fcb9`](#source-pubmed-observation-pmid-28396341-2025-01-03-628404c7fcb9))

## Sources

<a id="source-pubmed-observation-pmid-28396341-2025-01-03-628404c7fcb9"></a>
- **Bioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention. · retained source version 1:2025-01-03:current:628404c7fcb96bf4b9797b5cfda9d78acda3083d570ad69a5a2404240b889574** — PubMed; class A. [Open source](https://pubmed.ncbi.nlm.nih.gov/28396341/) (`pubmed-observation-pmid-28396341-2025-01-03-628404c7fcb9`)

## Correction lineage

No correction is recorded for this version.

## Reporting boundaries and unknowns

PeptideScanner reproduces bounded bibliographic metadata attributed to PubMed. It does not summarize or endorse the article's findings.

- Sources outside the selected public PeptideScanner bundle may exist and are not represented by this object.
- This object does not determine whether cited records agree, corroborate one another, or establish scientific truth.
- This object does not determine safety, efficacy, causality, or suitability for any person.

Methodology: https://peptidescanner.com/methodology/
Medical disclaimer: https://peptidescanner.com/medical-disclaimer/

## Suggested citation

PeptideScanner. "Bioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention." Version 1, published 2026-08-13. https://peptidescanner.com/evidence/v1/objects/pubmed-pmid-28396341-linaclotide-v1.json SHA-256: 5deb397ed9a9a369ead090e30697e38ec7a5e87f4135f5fc07fb08c26ba70f90.